FGFR1 activation is a known driver in various malignant diseases such as breast, prostate, myeloproliferative neoplasms, AML, ALL, CML, glioblastoma, and lung cancer [61–65]. The gene discussed is FGFR1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.